EPS (Diluted) for Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's current diluted EPS (TTM) is $2.38. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$2.38
YoY change
+55.2%
5Y CAGR
N/A
Peak year (2019)
$3.33
Latest annual
$1.94
EPS (Diluted) history chart for Boston Scientific (BSX) from 1991 to 2025
EPS (Diluted) history table for Boston Scientific (BSX) from 1991 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $1.94 | +55.2% | ||
| 2024 | $1.25 | +16.5% | ||
| 2023 | $1.07 | +140.6% | ||
| 2022 | $0.45 | -35.1% | ||
| 2021 | $0.69 | -946.1% | ||
| 2020 | $-0.08 | -102.4% | ||
| 2019 | $3.33 | +180.0% | ||
| 2018 | $1.19 | +1493.0% | ||
| 2017 | $0.07 | -70.1% | ||
| 2016 | $0.25 | -238.9% | ||
| 2015 | $-0.18 | +100.0% | ||
| 2014 | $-0.09 | 0.0% | ||
| 2013 | $-0.09 | -96.9% | ||
| 2012 | $-2.89 | -1096.6% | ||
| 2011 | $0.29 | -141.4% | ||
| 2010 | $-0.70 | +2.9% | ||
| 2009 | $-0.68 | -50.0% | ||
| 2008 | $-1.36 | +312.1% | ||
| 2007 | $-0.33 | -88.3% | ||
| 2006 | $-2.81 | -474.7% | ||
| 2005 | $0.75 | -39.5% | ||
| 2004 | $1.24 | +121.4% | ||
| 2003 | $0.56 | +24.4% | ||
| 2002 | $0.45 | -792.3% | ||
| 2001 | $-0.07 | -114.4% | ||
| 2000 | $0.45 | 0.0% | ||
| 1999 | $0.45 | -232.4% | ||
| 1998 | $-0.34 | -300.0% | ||
| 1997 | $0.17 | -19.0% | ||
| 1996 | $0.21 | +1826.6% | ||
| 1995 | $0.01 | -94.3% | ||
| 1994 | $0.19 | +5.6% | ||
| 1993 | $0.18 | +28.6% | ||
| 1992 | $0.14 | +27.3% | ||
| 1991 | $0.11 | — |
EPS (Diluted) values are taken from Boston Scientific's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Boston Scientific (BSX) diluted EPS is $1.94 – surged 55.2% year-over-year.
Boston Scientific diluted EPS peaked at $3.33 in 2019; the latest annual figure is $1.94 in 2025 (41.8% below peak).
Across the available history, diluted EPS reached its high of $3.33 in 2019 and its low of $-2.89 in 2012.
Boston Scientific (BSX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $13.16.
Boston Scientific EPS (Diluted) by Year
Boston Scientific EPS (Diluted) 2025: $1.94
Boston Scientific diluted EPS in 2025 was $1.94, surged 55.2% from 2024.
Boston Scientific EPS (Diluted) 2024: $1.25
Boston Scientific diluted EPS in 2024 was $1.25, grew 16.5% from 2023.
Boston Scientific EPS (Diluted) 2023: $1.07
Boston Scientific diluted EPS in 2023 was $1.07, surged 140.6% from 2022.
Boston Scientific EPS (Diluted) 2022: $0.45
Boston Scientific diluted EPS in 2022 was $0.45, plunged 35.1% below 2021.
Boston Scientific EPS (Diluted) 2021: $0.69
Boston Scientific diluted EPS in 2021 was $0.69.
See more financial history for Boston Scientific (BSX).
Sector peers — EPS (Diluted)
Companies in the same sector as Boston Scientific, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Boston Scientific's diluted EPS?
- Latest reported diluted EPS for Boston Scientific (BSX) is $2.38 (period ending March 31, 2026).
How has Boston Scientific diluted EPS changed year-over-year?
- Boston Scientific (BSX) diluted EPS changed +55.2% year-over-year on the latest annual filing.
When did Boston Scientific diluted EPS hit its highest annual value?
- Boston Scientific diluted EPS reached its highest annual value of $3.33 in 2019.
What was Boston Scientific diluted EPS in 2024?
- Boston Scientific (BSX) diluted EPS in 2024 was $1.25.
What was Boston Scientific diluted EPS in 2025?
- Boston Scientific (BSX) diluted EPS in 2025 was $1.94.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.